Skip to content

Lunai Bioworks Inc.: 10-Q filed 2025-05-15

What Lunai Bioworks Inc. reported in its quarterly report filed 2025-05-15 (fiscal Q3 2025): 39 published measures, 118 facts as tagged in accession 0001731122-25-000765.

This filing

Form
10-Q (quarterly report)
Filed
2025-05-15
Fiscal period
fiscal Q3 2025
Accession
0001731122-25-000765 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Lunai Bioworks Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-03-31117,726,120USD
At 2024-06-30163,129,450USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-03-3129,339,269USD
At 2024-06-3031,152,306USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-03-3188,386,851USD
At 2024-06-30131,977,144USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-03-31923,002USD
At 2024-06-30220,467USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-31189,176USD90
2024-07-01 to 2025-03-31-51,275,253USD274
2024-10-01 to 2024-12-31-7,252,394USD92
2024-07-01 to 2024-09-30-44,212,035USD92
2024-01-01 to 2024-03-31-58,990,070USD91
2023-07-01 to 2024-03-31-72,694,219USD275
2023-10-01 to 2023-12-31-4,529,121USD92
2023-07-01 to 2023-09-30-9,175,028USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-07-01 to 2025-03-31-6,063,511USD274
2023-07-01 to 2024-03-31-8,557,649USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-07-01 to 2025-03-318,204,415USD274
2023-07-01 to 2024-03-318,050,737USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-07-01 to 2025-03-31-1,464,389USD274
2023-07-01 to 2024-03-31-1,206,806USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-03-31-383,730,334USD
At 2024-06-30-332,455,081USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-01-01 to 2025-03-31162,334,574shares90
2024-07-01 to 2025-03-31161,377,448shares274
2024-01-01 to 2024-03-31109,249,637shares91
2023-07-01 to 2024-03-3179,754,095shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-01-01 to 2025-03-31163,930,470shares90
2024-07-01 to 2025-03-31161,377,448shares274
2024-01-01 to 2024-03-31109,249,637shares91
2023-07-01 to 2024-03-3179,754,095shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD/shares90
2024-07-01 to 2025-03-31-0.32USD/shares274
2024-01-01 to 2024-03-31-0.54USD/shares91
2023-07-01 to 2024-03-31-0.91USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD/shares90
2024-07-01 to 2025-03-31-0.32USD/shares274
2024-01-01 to 2024-03-31-0.54USD/shares91
2023-07-01 to 2024-03-31-0.91USD/shares275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-03-31393,119USD
At 2024-06-30482,121USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-03-311,499,199USD90
2024-10-01 to 2024-12-31558,631USD92
2024-07-01 to 2024-09-30357,648USD92
2024-01-01 to 2024-03-311,861,601USD91
2023-10-01 to 2023-12-31999,228USD92
2023-07-01 to 2023-09-30983,829USD92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-4,162,492USD90
2024-07-01 to 2025-03-31-62,047,361USD274
2024-01-01 to 2024-03-31-51,380,840USD91
2023-07-01 to 2024-03-31-64,535,029USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-03-313,668,054USD
At 2024-06-301,997,643USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-03-3128,841,640USD
At 2024-06-3030,309,917USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-03-31112,642,272USD
At 2024-06-30159,330,161USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-03-3116,172USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-03-31964,389USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-01-01 to 2025-03-314,162,492USD90
2024-07-01 to 2025-03-3162,047,361USD274
2024-01-01 to 2024-03-3151,380,840USD91
2023-07-01 to 2024-03-3164,535,029USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-03-31162,392,907shares
At 2024-06-30158,452,644shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-03-31923,002USD
At 2024-06-30220,467USD
At 2024-03-31312,697USD
At 2023-06-301,874,480USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-03-31471,325,333USD
At 2024-06-30464,587,224USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-03-31775,611USD
At 2024-06-30-170,846USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-03-3188,386,851USD
At 2024-12-3182,059,318USD
At 2024-09-3098,086,999USD
At 2024-06-30131,977,144USD
At 2024-03-31134,405,556USD
At 2023-12-3143,595,536USD
At 2023-09-3046,746,312USD
At 2023-06-3046,502,111USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-03-31992,357USD
At 2024-06-301,269,633USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-03-31113,664,947USD
At 2024-06-30160,649,686USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-03-315,715,737USD
At 2024-06-305,311,324USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-03-31943,302USD
At 2024-06-30668,929USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-01-01 to 2025-03-31189,176USD90
2024-07-01 to 2025-03-31-51,275,253USD274
2024-01-01 to 2024-03-31-58,990,070USD91
2023-07-01 to 2024-03-31-72,694,219USD275

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-01-01 to 2025-03-314,812,390USD90
2024-07-01 to 2025-03-31-50,328,796USD274
2024-01-01 to 2024-03-31-57,928,869USD91
2023-07-01 to 2024-03-31-71,630,367USD275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-314,224,590USD90
2024-07-01 to 2025-03-3113,878,963USD274
2024-01-01 to 2024-03-317,652,379USD91
2023-07-01 to 2024-03-3119,558,981USD275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-01-01 to 2025-03-3131,975USD90
2024-07-01 to 2025-03-3196,469USD274
2024-01-01 to 2024-03-3130,305USD91
2023-07-01 to 2024-03-3190,727USD275

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-01-01 to 2025-03-31188,685USD90
2024-07-01 to 2025-03-31537,656USD274
2024-01-01 to 2024-03-31303,802USD91
2023-07-01 to 2024-03-31758,057USD275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-01-01 to 2025-03-314,351,668USD90
2024-07-01 to 2025-03-3110,772,108USD274
2024-01-01 to 2024-03-31-7,609,230USD91
2023-07-01 to 2024-03-31-8,159,190USD275

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-07-01 to 2025-03-3115,995USD274
2023-07-01 to 2024-03-3112,692USD275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-07-01 to 2025-03-312,277,375USD274
2023-07-01 to 2024-03-312,110,232USD275

Inspect the source

Entity
Lunai Bioworks Inc. / CIK 0001527728
Captured
2026-09-19T11:18:43.497Z
SEC response SHA-256
ac98dc0ce9d3f6a81ccca9ca1f946e5772f94eabe3529dac2d726fef17abed57

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001527728.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))